Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07494526Not Yet Recruiting

Chronic Kidney Disease and Metabolic Disorders in the Elderly

Role: collaborator

NCT07129148Not ApplicableNot Yet Recruiting

Mobile Health and Wearable Devices for Diabetes Complication Management

Role: collaborator

NCT07034807Not ApplicableNot Yet Recruiting

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2

Role: collaborator

NCT07032116Not Yet Recruiting

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Role: collaborator

All 4 trials loaded